CAS No. |
13060-14-5 |
中文名称 |
((1S,3aR,4S,6aR)-1,4-双(3,4,5-三甲氧基苯基)四氢-1H,3H-呋喃并[3,4-c]呋喃) |
英文名称 |
(1S,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan |
别名 |
Lrioresinol B dimethyl ether;(1S,3aR,4S,6aR)-Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-1H,3H-furo[3,4-c]furan;(+)-Yangabin;C10894;YANGAMBIN;(+)-O,O-Dimethyl lirioresinol B;(1S)-1β,4β-Bis(3,4,5-trimethoxyphenyl)-3aβ,4,6,6aβ-tetrahydro-1H,3H-furo[3,4-c]furan;(1β,5β)-2β,6β-Bis(3,4,5-trimethoxyphenyl)-3,7-dioxabicyclo[3.3.0]octane |
标准英文名 |
(1S,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan |
MDL No. |
MFCD04307767 |
分子式 |
C24H30O8 |
分子量 |
446.50
|
精确分子量 |
446.19
|
SMILES |
COC1=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC |
标准SMILES |
COC1C=C(C=C(OC)C=1OC)[C@H]1OC[C@@H]2[C@H](OC[C@@H]21)C1=CC(OC)=C(OC)C(=C1)OC |
用途 |
Yangambin is used for its potent purgative, anti-parasitic, anti-inflammatory, and anti-allergic properties; it is clinically applied in the treatment of conditions such as erysipelas, mastitis, parotitis (mumps), impetigo, smallpox, and disorders involving muscle, bone, and vascular "Qi Ha" syndrome in traditional medicine. It acts as a selective PAF receptor antagonist, inhibits Ca²⁺ influx via modulation of Ca²⁺ channels, leading to reduced intracellular Ca²⁺ concentration ([Ca²⁺]i) in vascular smooth muscle cells and subsequent peripheral vasodilation; it also exhibits anti-allergic activity by inhibiting β-hexosaminidase (IC₅₀ = 33.8 μM) and shows anti-inflammatory effects (IC₅₀ = 37.4 μM). |
InChIKey |
HRLFUIXSXUASEX-RZTYQLBFSA-N |